A new study suggests the cumulative effects of ionizing radiation from CT scans may raise a person's lifetime risk of ...

Mycobacteria are the world's most deadly bacteria --c ausing infectious diseases including tuberculosis (TB), which alone kills more than one million people each year. New drugs to fight these ...

Abstract: Lung cancer is one of the fatal diseases whose early diagnosis is essential to mitigate the death rate. Computed Tomography (CT) scans are widely used for lung cancer diagnosis, but manual ...

Objective: This study aims to investigate the relationship between nutritional status and quality of life (QOL) in patients with lung cancer, analyze the clinical application of nutritional support, ...

After being diagnosed with stage 3A breast cancer, I was determined to help others — one topless DM at a time. "This is the goal of sending my videos – to remind us to talk to each other and take care ...

Increased use of chest X-rays leads to earlier lung cancer diagnosis and improved survival rates, suggests a new study.

The diagnosis was lung cancer, leading to surgery to remove a tumor. Understandably, it led Williams to worry about how much time she had left. "It was concerning. I did kind of think about what ...

When you have lung cancer, you may notice that it even seems to affect your mouth. It could be drier, or more sensitive, or painful, or have sores. Food might not even taste the way it usually does.

BioNTech has shown why it made small cell lung cancer (SCLC) a priority for its PD-L1xVEGF-A bispecific. The biotech linked BNT327 to a median overall survival (OS) of 16.8 months in a Chinese ...

today announces two poster presentations at the European Society for Medical Oncology (ESMO)'s European Lung Cancer Congress 2025 (ELCC 2025). The studies demonstrate how Volition's Nu.Q ...

Monday's images taken by Maxar Technologies show two aircraft east of Scarborough Shoal, which China calls "Huangyan Dao". In recent years, Chinese coast guard vessels have clashed frequently with ...

John­son & John­son re­leased new da­ta sug­gest­ing its lung can­cer com­bi­na­tion Ry­bre­vant and Laz­cluze beat As­traZeneca’s Tagris­so on over­all sur­vival.